| 1 |
Susan E. Barrie |
British Technology Group Limited |
2 |
| 1 |
David Trigger |
Ethical Pharmaceuticals (U.K.) Limited |
2 |
| 1 |
Richard George A. Rolls |
The Procter & Gamble |
2 |
| 1 |
Stephen David Watkins |
Quest International B.V. |
2 |
| #5 |
Steven Neville Chatfield |
Glaxo Wellcome |
1 |
| #5 |
Michael J. Keen |
Burroughs Wellcome |
1 |
| #5 |
Rodney Christopher Hall |
British Telecommunications Public Limited |
1 |
| #5 |
Stephen Raymond Wells |
British Telecommunications Public Limited |
1 |
| #5 |
Julie Goodall |
Quest International B.V. |
1 |
| #5 |
Christopher Charles Piddock |
Quest International B.V. |
1 |
| #5 |
Katherine A. Maume |
Quest International B.V. |
1 |
| #5 |
Keith Douglas Perring |
Quest International B.V. |
1 |
| #5 |
Graham John Bratton |
British Petroleum |
1 |
| #5 |
Shane Robert McGill |
Mcgill Technology Limited |
1 |
| #5 |
Nicholas T. Rapson |
Glaxo Wellcome |
1 |
| #5 |
Alan Forbes Provan |
Givaudan Sa |
1 |
| #5 |
John Martin Behan |
Quest International B.V. |
1 |
| #5 |
Benedict Deefholts |
Buhler Sortex |
1 |
| #5 |
Phillip Shaw |
Quest International B.V. |
1 |
| #5 |
Robert Semos |
British Telecommunications Public Limited |
1 |
| #5 |
Trevor Alan Fuller |
Delphi Technologies |
1 |
| #5 |
Keith W. Sheffield |
Crews |
1 |